Assessment of panobacumab as adjunctive immunotherapy for the treatment of nosocomial Pseudomonas aeruginosa pneumonia
Crossref DOI link: https://doi.org/10.1007/s10096-014-2156-1
Published Online: 2014-05-24
Published Print: 2014-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Que, Y.-A.
Lazar, H.
Wolff, M.
François, B.
Laterre, P.-F.
Mercier, E.
Garbino, J.
Pagani, J.-L.
Revelly, J.-P.
Mus, E.
Perez, A.
Tamm, M.
Rouby, J.-J.
Lu, Q.
Chastre, J.
Eggimann, P.
Text and Data Mining valid from 2014-05-24